ARNI / Arno Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Arno Therapeutics, Inc.
US ˙ OTCPK

Deler fremragende 49,349,749 shares
Insideraktier21.781.427 shares
Insider ejerskab44,14 %
Total Insiders17
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
8045 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
7090 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Arno Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Arie Belldegrun Director - [D] 2.262.838 2.262.838
William F Phd Hamilton Director - [D] 22.079 22.079
Lawrence A Kenyon 0
Tomer Kariv Director - [D] 496.068 496.068
Mattes Glenn R. President & CEO, Director - [D] [O] 77.203 77.203
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Jay Moorin Director - [D] 1.285.716 1.285.716
Scott L Navins Treasurer - [O] 149.532 149.532
Stefan Proniuk VP of Product Development - [O] 10.047 10.047
Yacov Reizman Director - [D] 306.287 306.287
Steven B Ruchefsky Director - [D] 4.472.905 4.472.905
S Donald Sussman - 714.285 714.285
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
David M Tanen Secretary, Director - [D] [O] 314.569 314.569
Randy H Thurman Director - [D] 10.000 10.000
Wexford Capital Lp - 2.827.844 2.827.844
Wexford GP LLC 10% Owner - [10%] 2.827.844 2.827.844
Jonathan J Zucker 10% Owner - [10%] 8.570.222 8.570.222
Alexander A Zukiwski VP & Chief Medical Officer, Director - [D] [O] 261.832 261.832

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ARNI / Arno Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-10-03 TANEN DAVID M 142.857 142.857 1 0.47
2016-08-15 Kariv Tomer 349.168 349.168
2016-08-15 Kariv Tomer 102.100 102.100
2016-08-15 Kariv Tomer 263.017 263.017
2016-08-15 Belldegrun Arie 714.285 714.285

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARNI / Arno Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ARNI / Arno Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2016-12-30 SUSSMAN S DONALD 4.285.111 4.285.111 361 0.0011
2013-10-04 WEXFORD CAPITAL LP 325 0,4800 325 0,4800 156

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARNI / Arno Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2017-01-09 3 Zucker Jonathan J ARNI Common Stock D 8.570.222
2017-01-09 3 Zucker Jonathan J ARNI Common Stock D 8.570.222
2017-01-03 2016-12-30 4 SUSSMAN S DONALD ARNI 2013 Series D Warrants S - Sale D 1,75 -1.383.702 0
2017-01-03 2016-12-30 4 SUSSMAN S DONALD ARNI 2012 Series A Warrants S - Sale D 1,14 -1.605.809 0
2017-01-03 2016-12-30 4 SUSSMAN S DONALD ARNI Common Stock S - Sale D -4.285.111 714.285
2016-10-05 2016-10-03 4 TANEN DAVID M ARNI 2016 Series F Warrants (right to buy) P - Purchase D 0,44 71.428 71.428
2016-10-05 2016-10-03 4 TANEN DAVID M ARNI Common Stock P - Purchase D 142.857 314.569
2016-09-08 2016-08-15 4 SUSSMAN S DONALD ARNI 2016 Series F Warrants (right to buy) P - Purchase D 0,44 357.142 357.142
2016-09-08 2016-08-15 4 SUSSMAN S DONALD ARNI Common Stock P - Purchase D 714.285 714.285
2016-08-17 2016-08-15 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI 2016 Series F Warrants (right to buy) P - Purchase I 0,44 357.142 357.142
2016-08-17 2016-08-15 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock P - Purchase I 714.285 2.262.838
2016-08-17 2016-08-15 4 Kariv Tomer Pontifax (Israel) II - Individual Investors L.P. ARNI 2016 Series F Warrants (right to buy) P - Purchase I 0,44 51.050 51.050
2016-08-17 2016-08-15 4 Kariv Tomer Pontifax (Israel) II L.P. ARNI 2016 Series F Warrants (right to buy) P - Purchase I 0,44 131.508 131.508
2016-08-17 2016-08-15 4 Kariv Tomer Pontifax (Cayman) II L.P. ARNI 2016 Series F Warrants (right to buy) P - Purchase I 0,44 174.584 174.584
2016-08-17 2016-08-15 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock P - Purchase I 102.100 496.068
2016-08-17 2016-08-15 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock P - Purchase I 263.017 1.277.905
2016-08-17 2016-08-15 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock P - Purchase I 349.168 1.696.495
2016-04-11 2016-04-07 4 TANEN DAVID M ARNI Stock Option (right to buy) A - Award D 0,37 88.628 88.628
2016-04-11 2016-04-07 4 HAMILTON WILLIAM F PHD ARNI Stock Option (right to buy) A - Award D 0,37 88.628 88.628
2016-04-11 2016-04-07 4 Belldegrun Arie ARNI Stock Option (right to buy) A - Award D 0,37 177.256 177.256
2016-04-11 2016-04-07 4 Proniuk Stefan ARNI Stock Option (right to buy) A - Award D 0,37 554.685 554.685
2016-04-11 2016-04-07 4 Reizman Yacov ARNI Stock Option (right to buy) A - Award D 0,37 88.628 88.628
2016-04-11 2016-01-12 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock P - Purchase I 0,3500 206.986 72 393.968
2016-04-11 2016-01-12 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock P - Purchase I 0,3500 533.208 187 1.014.888
2016-04-11 2016-01-12 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock P - Purchase I 0,3500 707.868 248 1.347.327
2016-04-11 2016-04-07 4 Ruchefsky Steven B ARNI Stock Option (right to buy) A - Award D 0,37 88.628 88.628
2016-04-11 2016-04-07 4 Zukiwski Alexander A ARNI Stock Option (right to buy) A - Award D 0,37 1.196.070 1.196.070
2016-01-14 3 Moorin Jay ARNI Common Stock D 1.285.716
2016-01-14 3 Moorin Jay ARNI Common Stock D 1.285.716
2016-01-14 2016-01-12 4 Zukiwski Alexander A ARNI Common Stock P - Purchase D 0,3500 144.806 51 261.832
2016-01-14 2016-01-12 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock P - Purchase I 0,3500 2.876.633 1.007 4.472.905
2016-01-14 2016-01-12 4 TANEN DAVID M By Trust ARNI Common Stock P - Purchase I 0,3500 362.015 127 362.015
2016-01-14 2016-01-12 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ARNI Common Stock P - Purchase I 0,3500 714.285 250 858.094
2016-01-14 2016-01-12 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock P - Purchase I 0,3500 1.448.062 507 1.548.543
2016-01-14 2016-01-12 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock P - Purchase I 0,3500 206.986 72 393.968
2016-01-14 2016-01-12 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock P - Purchase I 0,3500 533.208 187 1.014.888
2016-01-14 2016-01-12 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock P - Purchase I 0,3500 707.868 248 1.347.327
2016-01-14 2016-01-12 4 Moorin Jay ARNI Stock Option (right to buy) A - Award D 0,30 88.648 88.648
2015-11-06 2015-11-04 4 Ruchefsky Steven B ARNI Stock Option (right to buy) A - Award D 0,36 48.399 48.399
2014-11-06 2014-11-04 4 Ruchefsky Steven B ARNI Stock Option (right to buy) A - Award D 0,85 136.784 136.784
2014-11-06 2014-10-28 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2013 Series E Warrants (right to buy) A - Award I 2,40 687.500 687.500
2014-11-06 2014-10-28 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2013 Series E Warrants (right to buy) D - Sale to Issuer I 2,40 -687.500 0
2014-11-06 2014-10-28 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 520.833 520.833
2014-11-06 2014-10-28 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -520.833 0
2014-02-26 2014-02-24 4 KENYON LAWRENCE A ARNI Stock Option (right to buy) A - Award D 2,23 223.445 223.445
2014-01-29 2014-01-24 4 THURMAN RANDY H ARNI Stock Option (right to buy) A - Award D 2,90 34.224 34.224
2014-01-28 2014-01-24 4 HAMILTON WILLIAM F PHD ARNI Stock Option (right to buy) A - Award D 2,90 34.224 34.224
2014-01-28 2014-01-24 4 TANEN DAVID M ARNI Stock Option (right to buy) A - Award D 2,90 34.224 34.224
2014-01-28 2014-01-24 4 Belldegrun Arie ARNI Stock Option (right to buy) A - Award D 2,90 68.448 68.448
2014-01-28 2014-01-24 4 Navins Scott L ARNI Stock Option (right to buy) A - Award D 2,90 125.457 125.457
2014-01-28 2014-01-24 4 Proniuk Stefan ARNI Stock Option (right to buy) A - Award D 2,90 171.877 171.877
2014-01-28 2014-01-24 4 Reizman Yacov ARNI Stock Option (right to buy) A - Award D 2,90 34.224 34.224
2014-01-28 2014-01-24 4 Kariv Tomer ARNI Stock Option (right to buy) A - Award D 2,90 34.224 34.224
2014-01-28 2014-01-24 4 Mattes Glenn R. ARNI Stock Option (right to buy) A - Award D 2,90 408.892 408.892
2014-01-28 2014-01-24 4 Ruchefsky Steven B ARNI Stock Option (right to buy) A - Award D 2,90 34.224 34.224
2014-01-28 2014-01-24 4 Zukiwski Alexander A ARNI Stock Option (right to buy) A - Award D 2,90 711.301 711.301
2013-11-08 2013-11-04 4 Zukiwski Alexander A ARNI Stock Option (right to buy) A - Award D 2,40 316.389 316.389
2013-11-06 2013-11-04 4 HAMILTON WILLIAM F PHD ARNI Stock Option (right to buy) A - Award D 2,40 68.448 68.448
2013-11-06 2013-11-04 4 TANEN DAVID M ARNI Stock Option (right to buy) A - Award D 2,40 68.448 68.448
2013-11-06 2013-11-04 4 THURMAN RANDY H ARNI Stock Option (right to buy) A - Award D 2,40 68.448 68.448
2013-11-06 2013-11-04 4 Belldegrun Arie ARNI Stock Option (right to buy) A - Award D 2,40 3.559.296 3.559.296
2013-11-06 2013-11-04 4 Proniuk Stefan ARNI Stock Option (right to buy) A - Award D 2,40 45.701 45.701
2013-11-06 2013-11-04 4 Reizman Yacov ARNI Stock Option (right to buy) A - Award D 2,40 68.448 68.448
2013-11-06 2013-11-04 4 Kariv Tomer ARNI Stock Option (right to buy) A - Award D 2,40 68.448 68.448
2013-11-06 2013-11-04 4 Mattes Glenn R. ARNI Stock Option (right to buy) A - Award D 2,40 386.697 386.697
2013-11-06 2013-11-04 4 Ruchefsky Steven B ARNI Stock Option (right to buy) A - Award D 2,40 205.344 205.344
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI 2013 Series E Warrant (right to buy) P - Purchase I 2,40 187.500 187.500
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI 2013 Series D Warrants (right to buy) P - Purchase I 4,00 187.500 187.500
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 145.833 145.833
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -145.833 0
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -145.833 0
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI 2013 Series E Warrant (right to buy) P - Purchase I 2,40 104.166 104.166
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ARNI 2013 Series D Warrants (right to buy) P - Purchase I 4,00 104.166 104.166
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI 2013 Series D Warrants (right to buy) P - Purchase I 4,00 104.166 104.166
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 125.000 125.000
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -125.000 0
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -125.000 0
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ARNI 2013 Series E Warrant (right to buy) P - Purchase I 2,40 104.166 104.166
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock P - Purchase I 187.500 379.294
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock A - Award I 2,4000 11.666 28 191.794
2013-11-05 2013-10-29 4 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock C - Conversion I 2,4000 155.523 373 180.128
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI Common Stock P - Purchase I 104.166 254.887
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ARNI Common Stock P - Purchase I 104.166 254.887
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI Common Stock A - Award I 2,4000 10.000 24 150.721
2013-11-05 2013-10-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI Common Stock C - Conversion I 2,4000 133.305 320 140.721
2013-11-05 2013-10-29 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 83.333 83.333
2013-11-05 2013-10-29 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -83.333 0
2013-11-05 2013-10-29 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -83.333 0
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI 2013 Series E Warrants (right to buy) P - Purchase I 2,40 83.333 83.333
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI 2013 Series D Warrants (right to buy) P - Purchase I 4,00 83.333 83.333
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 62.500 62.500
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -62.500 0
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -62.500 0
2013-11-05 2013-10-29 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock A - Award I 2,4000 6.666 16 100.481
2013-11-05 2013-10-29 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock C - Conversion I 2,4000 88.871 213 93.815
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock P - Purchase I 83.332 174.644
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock A - Award I 2,4000 5.000 12 91.312
2013-11-05 2013-10-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock C - Conversion I 2,4000 66.652 160 86.312
2013-10-31 2013-10-29 4 HAMILTON WILLIAM F PHD ARNI 2013 Series E Warrants (right to buy) P - Purchase D 2,40 20.833 20.833
2013-10-31 2013-10-29 4 HAMILTON WILLIAM F PHD ARNI 2013 Series D Warrants (right to buy) P - Purchase D 4,00 20.833 20.833
2013-10-31 2013-10-29 4 HAMILTON WILLIAM F PHD ARNI Common Stock P - Purchase D 20.833 22.079
2013-10-31 2013-10-29 4 Proniuk Stefan ARNI 2012 Series B Warrants (right to buy) A - Award D 2,40 8.333 8.333
2013-10-31 2013-10-29 4 Proniuk Stefan ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer D 2,40 -8.333 0
2013-10-31 2013-10-29 4 Proniuk Stefan ARNI 8% Senior Convertible Debentures C - Conversion D 2,40 -8.333 0
2013-10-31 2013-10-29 4 Proniuk Stefan ARNI Common Stock A - Award D 2,4000 666 2 10.047
2013-10-31 2013-10-29 4 Proniuk Stefan ARNI Common Stock C - Conversion D 2,4000 8.887 21 9.381
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II - Individual Investors L.P. ARNI 2013 Series E Warrants (right to buy) P - Purchase I 2,40 59.558 59.558
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II - Individual Investors L.P. ARNI 2013 Series D Warrants (right to buy) P - Purchase I 2,40 59.558 59.558
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II - Individual Investors L.P. ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 59.558 59.558
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II - Individual Investors L.P. ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -59.558 0
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II - Individual Investors L.P. ARNI 8% Senior Convertible Debenures C - Conversion I 2,40 -59.558 0
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II L.P. ARNI 2013 Series E Warrants (right to buy) P - Purchase I 2,40 153.426 153.426
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II L.P. ARNI 2013 Series D Warrants (right to buy) P - Purchase I 2,40 153.426 153.426
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II L.P. ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 153.426 153.426
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II L.P. ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -153.426 0
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Israel) II L.P. ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -153.426 0
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Cayman) II L.P. ARNI 2013 Series D Warrants (right to buy) P - Purchase I 2,40 203.682 203.682
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Cayman) II L.P. ARNI 2013 Series E Warrants (right to buy) P - Purchase I 2,40 203.682 203.682
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Cayman) II L.P. ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 203.682 203.682
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Cayman) II L.P. ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -203.682 0
2013-10-31 2013-10-29 4 Kariv Tomer Pontifax (Cayman) II L.P. ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -203.682 0
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock P - Purchase I 59.558 186.982
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock A - Award I 2,4000 4.764 11 127.424
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock C - Conversion I 2,4000 63.516 152 122.660
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock P - Purchase I 153.426 481.680
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock A - Award I 2,4000 12.274 29 328.254
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock C - Conversion I 2,4000 163.620 393 315.980
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock P - Purchase I 203.682 639.459
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock A - Award I 2,4000 16.294 39 435.777
2013-10-31 2013-10-29 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock C - Conversion I 2,4000 217.216 521 419.483
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI 2013 Series E Warrants (right to buy) P - Purchase D 2,40 20.833 20.833
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI 2013 Series D Warrants (right to buy) P - Purchase D 4,00 20.833 20.833
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI 2012 Series B Warrants (right to buy) A - Award D 2,40 20.833 20.833
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer D 2,40 -20.833 0
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI 8% Senior Convertible Debentures C - Conversion D 2,40 -20.833 0
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI Common Stock P - Purchase D 20.833 77.203
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI Common Stock A - Award D 2,4000 1.666 4 56.370
2013-10-31 2013-10-29 4 Mattes Glenn R. ARNI Common Stock C - Conversion D 2,4000 22.218 53 54.704
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2013 Series E Warrants (right to buy) P - Purchase I 2,40 687.500 687.500
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2013 Series D Warrants (right to buy) P - Purchase I 4,00 687.500 687.500
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2012 Series B Warrants (right to buy) A - Award I 2,40 520.833 520.833
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer I 2,40 -520.833 0
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI 8% Senior Convertible Debentures C - Conversion I 2,40 -520.833 0
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock A - Award I 2,4000 41.666 100 1.596.272
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock P - Purchase I 687.500 1.554.606
2013-10-31 2013-10-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock C - Conversion I 2,4000 555.440 1.333 867.106
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI 2013 Series D Warrants (right to buy) P - Purchase D 4,00 41.666 41.666
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI 2013 Series E Warrants (right to buy) P - Purchase D 2,40 41.666 41.666
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI 2012 Series B Warrants (right to buy) A - Award D 2,40 62.500 62.500
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI 2012 Series B Warrants (right to buy) D - Sale to Issuer D 2,40 -62.500 0
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI 8% Senior Convertible Debentures C - Conversion D 2,40 -62.500 0
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI Common Stock P - Purchase D 41.666 117.026
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI Common Stock A - Award D 2,4000 5.000 12 75.360
2013-10-31 2013-10-29 4 Zukiwski Alexander A ARNI Common Stock C - Conversion D 2,4000 66.652 160 70.360
2013-10-09 2013-10-04 4 WEXFORD CAPITAL LP By: Wexford Spectrum Investors LLC ARNI Common Stock S - Sale I 0,4800 -325 -0 2.827.844
2013-06-05 2013-05-28 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock J - Other I 0,3000 9.529 3 473.156
2013-06-05 2013-05-28 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock J - Other I 0,3000 24.548 7 1.218.883
2013-06-05 2013-05-28 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock J - Other I 0,3000 32.589 10 1.618.140
2013-06-04 2013-05-28 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock J - Other I 0,3000 80.556 24 2.493.331
2013-06-03 2013-05-28 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock J - Other I 0,3000 12.889 4 39.555
2013-06-03 2013-05-28 4 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock J - Other I 0,3000 9.667 3 157.286
2013-06-03 2013-05-28 4 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock J - Other I 0,3000 22.556 7 196.841
2013-06-03 2013-05-28 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI Common Stock J - Other I 0,3000 19.333 6 59.333
2013-05-30 2013-05-28 4 Proniuk Stefan ARNI Common Stock J - Other D 0,3000 1.289 0 3.955
2013-05-30 2013-05-28 4 Mattes Glenn R. ARNI Common Stock J - Other D 0,3000 3.222 1 259.888
2013-05-30 2013-05-28 4 Zukiwski Alexander A ARNI Common Stock J - Other D 0,3000 9.667 3 29.667
2013-05-23 2013-05-22 4 THURMAN RANDY H ARNI Common Stock P - Purchase D 0,5000 2.500 1 10.000
2013-05-23 2013-05-21 4 THURMAN RANDY H ARNI Common Stock P - Purchase D 0,5000 7.500 4 7.500
2013-05-07 2013-04-29 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock J - Other I 0,3000 13.333 4 26.666
2013-05-07 2013-04-29 4 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock J - Other I 0,3000 10.000 3 147.619
2013-05-07 2013-04-29 4 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock J - Other I 0,3000 23.333 7 174.285
2013-05-07 2013-04-29 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI Common Stock J - Other I 0,3000 20.000 6 40.000
2013-05-07 2013-04-29 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock J - Other I 0,3000 16.291 5 463.627
2013-05-07 2013-04-29 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock J - Other I 0,3000 41.967 13 1.194.335
2013-05-07 2013-04-29 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock J - Other I 0,3000 55.714 17 1.585.551
2013-05-07 2013-04-29 4 Mattes Glenn R. ARNI Common Stock J - Other D 0,3000 3.333 1 256.666
2013-05-07 2013-04-29 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock J - Other I 0,3000 83.333 25 2.412.775
2013-05-07 2013-04-29 4 Zukiwski Alexander A ARNI Common Stock J - Other D 0,3000 10.000 3 20.000
2013-05-06 2013-04-29 4 Proniuk Stefan ARNI Common Stock J - Other D 0,3000 1.333 0 2.666
2013-04-15 2013-03-27 4 Belldegrun Arie Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ARNI Common Stock J - Other I 0,3000 13.333 4 13.333
2013-04-15 2013-03-27 4 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock J - Other I 0,3000 10.000 3 137.619
2013-04-15 2013-03-27 4 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock J - Other I 0,3000 23.333 7 150.952
2013-04-15 2013-03-27 4 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ARNI Common Stock J - Other I 0,3000 20.000 6 20.000
2013-04-11 2013-03-27 4 Zukiwski Alexander A ARNI Common Stock J - Other D 0,3000 10.000 3 10.000
2013-04-10 2013-03-27 4 Proniuk Stefan ARNI Common Stock J - Other D 0,3000 1.333 0 1.333
2013-04-10 2013-03-27 4 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock J - Other I 0,3000 9.529 3 447.336
2013-04-10 2013-03-27 4 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock J - Other I 0,3000 24.548 7 1.152.368
2013-04-10 2013-03-27 4 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock J - Other I 0,3000 32.589 10 1.529.837
2013-04-09 2013-03-27 4 Mattes Glenn R. ARNI Common Stock J - Other D 0,3000 3.333 1 253.333
2013-04-09 2013-03-27 4 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock J - Other I 0,3000 83.333 25 2.329.442
2013-02-12 3 Ruchefsky Steven B By Commercial Street Capital, LLC ARNI Common Stock I 2.246.109
2013-02-04 3 Mattes Glenn R. ARNI Common Stock D 250.000
2013-02-01 2013-01-30 4 THURMAN RANDY H ARNI Stock Option (right to buy) A - Award D 0,30 200.000 200.000
2013-01-29 3 Belldegrun Arie ARNI Common Stock D 24.922
2013-01-29 3 Belldegrun Arie Belldegrun Family Trust ARNI Common Stock I 127.619
2013-01-29 3 Belldegrun Arie Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ARNI Common Stock I 317.155
2013-01-29 3 Belldegrun Arie MDRB Partnership, L.P. ARNI Common Stock I 127.619
2013-01-29 3 Kariv Tomer By Pontifax (Israel) II L.P. ARNI Common Stock I 1.127.820
2013-01-29 3 Kariv Tomer By Pontifax (Israel) II - Individual Investors L.P. ARNI Common Stock I 437.807
2013-01-29 3 Kariv Tomer By Pontifax (Cayman) II L.P. ARNI Common Stock I 1.497.248
2013-01-28 3 HAMILTON WILLIAM F PHD ARNI Common Stock D 9.968
2013-01-28 3 Reizman Yacov By FCC Ltd. ARNI Common Stock I 306.287
2013-01-25 3 TANEN DAVID M By spouse for minor children ARNI Common Stock I 149.532
2013-01-25 3 TANEN DAVID M ARNI Common Stock D 1.373.696
2013-01-25 3 Navins Scott L ARNI Common Stock D 149.532
2013-01-25 3 DAVIDSON CHARLES E By: Wexford Spectrum Investors LLC ARNI Common Stock I 2.828.169
2013-01-25 3 DAVIDSON CHARLES E By: Kappa Investors LLC ARNI Common Stock I 418.876
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista